Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NALIRI-VT vs VIT in Advanced Ewing's Sarcoma
NCT07092306Phase 2Not yet recruiting
- Start
- Aug 2025
- Primary completion
- May 2027
- Modality
- Lipid-based Nanoparticles, Small Molecules
01
Overview
A Phase 2 trial of irinotecan liposome injection in Ewing sarcoma. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
irinotecan liposome injection
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on NCT07092306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07092306.